Newron Pharmaceuticals
NWRN.SW
#7185
Rank
ยฃ0.37 B
Marketcap
ยฃ18.60
Share price
3.20%
Change (1 day)
174.15%
Change (1 year)

Revenue for Newron Pharmaceuticals (NWRN.SW)

Revenue in 2024: ยฃ40.11 Million

According to Newron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ40.11 Million. In 2024 the company made a revenue of ยฃ40.11 Million an increase over the revenue in the year 2023 that were of ยฃ7.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Newron Pharmaceuticals from 2005 to 2024

Annual revenue

Year Revenue Change
2024ยฃ40.11 M434.12%
2023ยฃ7.51 M53.16%
2022ยฃ4.9 M0.17%
2021ยฃ4.89 M0.9%
2020ยฃ4.85 M-17.97%
2019ยฃ5.91 M71.22%
2018ยฃ3.45 M-71.42%
2017ยฃ12.08 M218.38%
2016ยฃ3.79 M94.46%
2015ยฃ1.95 M37.42%
2014ยฃ1.42 M-61.25%
2013ยฃ3.66 M-58.6%
2012ยฃ8.85 M111.93%
2011ยฃ4.17 M568.93%
2010ยฃ0.62 M-77.14%
2009ยฃ2.73 M-33.76%
2008ยฃ4.12 M-8.02%
2007ยฃ4.48 M280.38%
2006ยฃ1.17 M
2005N/A